ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2607

Fatigue in Ankylosing Spondylitis: A Multivariable Analysis Implicates Inflammation As the Key Determinant of Disability

Mohamed Bedaiwi1, Arane Thavaneswaran2, Nigil Haroon3, Ammepa Anton4 and Robert D. Inman5, 1Division of Rheumatology, Toronto Western Hospital, clinical and research fellow, Toronto, ON, Canada, 2University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 3Toronto Western Research Institute, Toronto, ON, Canada, 4Rheumatology, University Health Network, Toronto, ON, Canada, 5Toronto Western Hospital, University of Toronto, Toronto, ON, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), fatigue and functional status

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment III

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Fatigue is one of the cardinal features of ankylosing spondylitis (AS). The clinical and laboratory correlates of fatigue in AS however are not well defined. In the current study we undertake a systematic analysis of fatigue in a longitudinal observation cohort of AS patients.

Methods:

A systematic review of 950 AS patients (671 male and 279 female) followed in a longitudinal clinic which entails regular clinic visits using a standardized protocol. Fatigue was recorded using the Fatigue Severity Scales (FSS). T tests were used to compare continuous variables and Chi-Squared tests for categorical variables. Multivariate analysis was conducted using logistic regression to assess associations between FSS and various clinical features. P-value <0.05 was used to define statistical significance.

Results:

In the univariate analysis there were a number of clinical variables showing association with FSS. This was followed by logistic regression analysis. Figure 1 outlines selected covariates based on a p-value<0.05 in univariate models and included in the full model. Stepwise selection was used to determine the variables most associated with (FSS). In the reduced model the clinical domains with the strongest correlation with FSS were morning stiffness, Bath AS Functional Index (BASFI), and Short Form (36) Health Survey (SF36-MCS). For patients with morning stiffness, there is an expected 2.13 increase in the FSS. For every unit increase in the BASFI, there is a 0.37 increase expected in the FSS. For every unit increase in the SF36-MCS, there is a 0.11 decrease in FSS.

Conclusion:

Fatigue continues a frequent and sometimes disabling aspect of AS. The strong correlation with stiffness suggests that these two variables may reflect a common underlying process. Since morning stiffness is considered a surrogate indicator of inflammation, fatigue may fall into this conceptual framework as well. The level of disability as measured by BASFI shows stronger correlation with fatigue than with mSASSS suggesting this fatigue may impose greater functional restrictions on patients than structural progression of the disease does. The reversed SF36-MCS correlation with FSS indicates more vitality, bodily pain, emotional, social and mental health functionality impairment in fatigued AS patient.

TABLE: Linear Regression Models to Assess Variables associated with Fatigue (FSS)

 

Full Model

Reduced Model

 

Covariate Estimate (SE)

p-value

Estimate (SE)

p-value

Age

0.05 (0.05)

0.29

—

—

Age at diagnosis of AS

-0.04 (0.06)

0.53

—

—

Sex

1.28 (2.28)

0.58

—

—

ESR

0.005 (0.05)

0.92

—

—

CRP

0.02 (0.05)

0.71

—

—

Enthesitis

3.84 (2.32)

0.12

—

—

Morning stiffness

2.47 (1.61)

0.15

2.13 (0.79)

0.01

Peripheral arthritis

-0.89 (1.44)

0.55

—

—

Nocturnal back pain

0.49 (1.09)

0.66

—

—

MSASS

-0.02 (0.04)

0.64

—

—

BASDAI

0.03 (0.29)

0.92

—

—

BASFI

0.51 (0.30)

0.11

0.37 (0.13)

0.009

ASQoL

0.14 (0.20)

0.50

—

—

EQ5D

-1.58 (3.30)

0.64

—

—

SF36-PCS

0.05 (0.08)

0.57

—

—

SF36-MCS

-0.05 (0.05)

0.39

-0.11 (0.03)

0.0005

HAQ

-1.80 (1.38)

0.21

—

—

NSAIDs

1.79 (1.14)

0.14

—

—

Biologics

1.14 (0.87)

0.21

—

—


Disclosure:

M. Bedaiwi,
None;

A. Thavaneswaran,
None;

N. Haroon,
None;

A. Anton,
None;

R. D. Inman,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fatigue-in-ankylosing-spondylitis-a-multivariable-analysis-implicates-inflammation-as-the-key-determinant-of-disability/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology